U.S. Markets closed

Why This IBD Stock Of The Day Is No Longer Sweating $5 Billion In Sales

ALLISON GATLIN
Why This IBD Stock Of The Day Is No Longer Sweating $5 Billion In Sales

Amgen stock is the IBD Stock Of The Day after the biggest biotech company prevailed in a patent battle against Novartis subsidiary Sandoz, protecting nearly $5 billion in 2019 U.S. sales.